-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B9hUbiDIpu+n2i445GGCqTqqYwVtxqBDlYtuRjVe27THmLuVaKMimdwHwUcGHjzS Qn8Ym1LrBKyseA5Lciop6g== 0000950156-10-000079.txt : 20100601 0000950156-10-000079.hdr.sgml : 20100531 20100601164845 ACCESSION NUMBER: 0000950156-10-000079 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100525 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100601 DATE AS OF CHANGE: 20100601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGI LABORATORIES, INC CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08568 FILM NUMBER: 10870170 BUSINESS ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 6096971441 MAIL ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IGI INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 8-K 1 d74496_igi8k.htm BODY OF FORM 8-K 8-K 1 dfc063006

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________

FORM 8-K


CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934


DATE OF REPORT (Date of earliest event reported): May 25, 2010


IGI LABORATORIES, INC.

(Exact name of registrant as specified in charter)


DELAWARE
(State or Other Jurisdiction of
Incorporation)

001-08568
(Commission
file number)

01-0355758
(I.R.S. Employer
Identification
Number)


105 Lincoln Avenue

Buena, New Jersey 08310

(Address of principal executive offices)(Zip Code)


(856) 697-1441

(Registrant’s telephone number, including area code)


Not Applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))

 

 

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))




Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.


On May 25, 2010, the Company received a notice (the "Notice") from NYSE Amex LLC ("NYSE Amex" or the “Exchange”) notifying the Company that the Company does not currently meet the Exchange's continued listing standards as set forth in Part 10 of the Exchange’s Company Guide (the "Company Guide"). Specifically, the Company is not in compliance with Section 1003(a)(iii) of the Company Guide because the Company has stockholder's equity of less than $6,000,000 and has losses from continuing operations and net losses in each of its last five fiscal years. The Company's stockholders' equity as reported on its Form 10-Q for the quarter ended March 31, 2010 was $5,779,000 and the Company has reported net losses for the 2009, 2008, 2007, 2006 and 2005 fiscal years.


The Company has been afforded the opportunity to submit a plan of compliance to the Exchange by June 24, 2010 addressing how it intends to regain compliance with Section 1003(a)(iii) of the Company Guide within nine months, or by February 25, 2011 (the “Plan”). In setting this truncated deadline for compliance, the Exchange Staff applied Section 1009(h) of the Company Guide which provides that the Exchange Staff may truncate the continued listing evaluation and follow up procedures if a company, within 12 months of the end of a plan period, is again determined to be below the continued listing standards. The Company was previously notified of its noncompliance with Sections 1003(a)(iii) and (ii) of the Company Guide by letters dated May 6, 2008 and September 16, 2008, respectively. The Company was below the continued listing standards for approximately 13 months, regaining compliance on June 18, 2009. The Exchange Staff determine d that both were related to the Company’s unsatisfactory operating results, including continuing losses.


If the Plan is accepted, the Company may be able to continue its listing during the Plan period, during which time the Company will be subjected to periodic reviews by the Exchange’s Staff to determine whether it is making progress consistent with the Plan. If the Company fails to make progress consistent with the Plan or to regain compliance with the continued listing standards by the end of the Plan period, the Exchange Staff will initiate delisting proceedings in accordance with Section 1010 and Part 12 of the Company Guide.


The Company intends to submit a compliance plan to the Exchange’s Staff in a timely manner which will outline its intended actions to regain compliance.


A copy of the Company's press release regarding receipt of the Notice is attached hereto as Exhibit 99.1.


Item 9.01 Financial Statements and Exhibits


(d) The following exhibits are furnished with this Form 8-K:


Exhibit No.

 

Description

 

 

 

Exhibit 99.1

 

Press Release dated June 1, 2010, Announcing Notice From the American Stock Exchange of the Company's Failure to Meet Continued Listing Standards




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

IGI LABORATORIES, INC.

 

 

 

 

Date: June 1, 2010

By:

/s/ Philip S. Forte

 

Name:

Philip S. Forte

 

Title:

Chief Financial Officer




EXHIBIT INDEX




Exhibit No.

 

Description

 

 

 

Exhibit 99.1

 

Press Release dated June 1, 2010, Announcing Notice From the American Stock Exchange of the Company's Failure to Meet Continued Listing Standards




 EX-99 2 ex99_74496.htm EXHIBIT 99.1 IGI LABORATORIES INC

Exhibit 99.1


News From


[ex99_74496003.jpg]


Buena, NJ 08310


Release Date: June 1, 2010


Contact:

Philip S. Forte

IGI Laboratories, Inc.

856-697-1441 ext. 363

www.igilabs.com


IGI LABORATORIES, INC.,

RECEIVES NOTICE FROM NYSE AMEX LLC OF NON-COMPLIANCE


BUENA, N.J.--(BUSINESS WIRE)--IGI Laboratories, Inc. (NYSE AMEX:IG), a New Jersey based formulation and manufacturing company announces notice from NYSE Amex LLC (“NYSE Amex” or the “Exchange”) of non-compliance.


On May 25, 2010, the Company received a notice (the "Notice") from NYSE Amex LLC notifying the Company that the Company does not currently meet the Exchange's continued listing standards as set forth in Part 10 of the Exchange’s Company Guide (the "Company Guide"). Specifically, the Company is not in compliance with Section 1003(a)(iii) of the Company Guide because the Company has stockholder's equity of less than $6,000,000 and has losses from continuing operations and net losses in each of its last five fiscal years. The Company's stockholders' equity as reported on its Form 10-Q for the quarter ended March 31, 2010 was $5,779,000 and the Company has reported net losses for the 2009, 2008, 2007, 2006 and 2005 fiscal years.


The Company has been afforded the opportunity to submit a plan of compliance to the Exchange by June 24, 2010 addressing how it intends to regain compliance with Section 1003(a)(iii) of the Company Guide within nine months, or by February 25, 2011 (the “Plan”). In setting this truncated deadline for compliance, the Exchange Staff applied Section 1009(h) of the Company Guide which provides that the Exchange Staff may truncate the continued listing evaluation and follow up procedures if a company, within 12 months of the end of a plan period, is again determined to be below the continued listing standards. The Company was previously notified of its noncompliance with Sections 1003(a)(iii) and (ii) of the Company Guide by letters dated May 6, 2008 and September 16, 2008, respectively. The Company was below the continued listing standards for approximately 13 months, regaining compliance on June 18, 2009. The Exchange Staff determine d that both were related to the Company’s unsatisfactory operating results, including continuing losses.



If the Plan is accepted, the Company may be able to continue its listing during the Plan period, during which time the Company will be subjected to periodic reviews by the Exchange’s Staff to determine whether it is making progress consistent with the Plan. If the Company fails to make progress consistent with the Plan or to regain compliance with the continued listing standards by the end of the Plan period, the Exchange Staff will initiate delisting proceedings in accordance with Section 1010 and Part 12 of the Company Guide.


The Company intends to submit a compliance plan to the Exchange’s Staff in a timely manner which will outline its intended actions to regain compliance.


About IGI Laboratories, Inc.

IGI Laboratories, Inc. engages in the development, manufacturing, filling, and packaging of topical, semi solid, and liquid products for pharmaceutical and cosmeceutical companies. The Company offers the patented Novasome® encapsulation technology which contributes value-added qualities to pharmaceutical and cosmeceutical products, providing improved dermal absorption and sustained release of the active molecule.


IGI Laboratories, Inc. “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. This press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, plans, objectives, expectations and intentions, and other statements contained in this press release that are not historical facts and statements identified by words such as "will," "possible," "one time," "provides an opportunity," "continue" or words of similar meaning. These statements are based on our current beliefs or expectations and are inherently subject to various risks and uncertainties, including those set forth under the caption "Risk Factors" in IGI Laboratories, Inc.’s most recent Annual Report on Form 10-K and Quarterly Reports on F orm 10-Q as filed with the Securities and Exchange Commission. Actual results may differ materially from these expectations due to changes in global political, economic, business, competitive, market and regulatory factors or IGI Laboratories, Inc.’s ability to implement business strategies. IGI Laboratories, Inc. does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.




 GRAPHIC 3 ex99_74496003.jpg begin 644 ex99_74496003.jpg M_]C_X``02D9)1@`!`@$!+`$L``#_[0J*4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!`!+`````$``0$L`````0`!.$))300-```````$````>#A"24T#\P`` M````"```````````.$))300*```````!```X0DE-)Q````````H``0`````` M```".$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`& M```````!`#(````!`%H````&```````!`#4````!`"T````&```````!.$)) M30/X``````!P``#_____________________________`^@`````________ M_____________________P/H`````/____________________________\# MZ`````#_____________________________`^@``#A"24T$"```````$``` M``$```)````"0``````X0DE-!!0```````0````#.$))300,``````CY```` M`0```'`````[```!4```37````C=`!@``?_8_^``$$I&248``0(!`$@`2``` M__X`)D9I;&4@=W)I='1E;B!B>2!!9&]B92!0:&]T;W-H;W"H(#4N,/_N``Y! M9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1 M#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X. M$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#/_``!$(`#L`<`,!(@`"$0$#$0'_W0`$``?_Q`$_```!!0$! M`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$``@,$ M!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21 MH;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7R MLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?' MU^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/! M4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3 M=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`, M`P$``A$#$0`_`.TZOT#I^/TO.RJ7Y3;JJ+K:W?:\DP]K'6-=M]?;])>9U]4Z MHY[`ZY];NK'`Z=:_I?3F`V6V5Z7^ MF"&M+[?S+K7?0JI^A_P_IKIJ`]3%&59^==E.=<]Q_>__P!&+NDW?[?> MA')I(2UL$`]5^3#9@8>GAD)2B-(R'DW,G'KRJ'X]N[T[!M=LFT])Z.S*P+M)_,: M2`&@IAY#U8B3J1(ZGRBI)))0-Q__T/1NO_\`(74O_"E__GMZ\8J_G*_ZS/RM M7L_7_P#D+J7_`(4O_P#/;UXQ5_.5_P!9GY6JURWRR&SU`RL,S*V_2`;]#):W\_8WV M7?R/3_X11\O(">O44V.>QF>+TZ\)XOHE_P`5X_4<]WC>T?Y&NZ_ MF+]F=]GD/J-_XJL'_KW_`)YM7K2\E^HW_BJP?^O?^>;5ZTG\S\X\F'X?_,G^ M^?RBM(F.Y3IG-#A!$A";8ZNSTGF0?HN[_P!I5R:W;C__T>TS<7ZXYF-D8CW] M-;3D,?42!?N#'@LGZ6W?M3+&- M=2?-YGJ/U(QGYK>I]&O/2L]CMX-;0ZHN,[II.W9ZGT;-GZ+_`(%6ZLCZWTL# MXLQZW-:[W;/8M7H/U9Z9T*MPQ6E]]@BW)L@O< M.=ND-KK_`.#8M9)(S-<.P[!`Q1$N,^J7[TOV(G]IV_HO6W>GN_ MX3T_?M_JKF>M]#^M?7,,8>7;T^NMMC;0ZH7;I;('T]S?SEUB249&.HI,\8F* M)-;4"\%TKZB]?Z3U"KJ&-DXC[J=VUM@LVG>UU3MVP-=]%ZZSIH^L/JO_`&J< M,T[?T?V46AVZ?S_7);LVK121ED,MZ6X\$,?R$@7=7HI5;W-=8-I#MAAT&8,\ M.5#ZWWY%'U=S'XKW,M#6RZOZ8K+V-R'MCZ.RAUGZ3\Q/#Z1^D__ MTO54DDDE*3$2G224P(L;]$AP\#H?\Y1-X;]-KF><2/O:BI(5V*D8NJ/#@I;V M?O#[T"V)U]+\9_Z*"=G\G_I(>KP*F[O9^\/O3&ZH?G#\JI:>7XJ0V^7_`$D+ MGV"=&P[)K'$G_7S0SD6OT8(^&I46[9T]/^UN_P"_*TSZ(X_L\)$2ZFO[JD#, M9Q.ZP\\CDGXIL3IG3<%SG86+3C.L^F:JVL)_K;`U6DD851X?JM-6+J^C_]D` M.$))300&```````'``0````!`0#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@ M0``9&5S8P`````````2D! M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+! M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H# MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P M!/X%#044%]@8&!A8&)P8W!D@& M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0) MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X- M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3 M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8# M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9 M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC M',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@ M;""8(,0@\"$<(4@A=2&A(B>K)]PH#2@_*'$H MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT, M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<-]1B)&9T:K1O!'-4=[1\!( M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4 MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5 M6^5<-5R&7-9=)UUX7&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I( M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5&YXS'DJ>8EYYWI& M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*" M](-7@[J$'82`A..%1X6KA@Z&I+CDTV3MI0@E(J4 M])5?EAMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H M4JC$J3>IJ:H_ MR#W(O,DZR;G*.,JWRS;+MLPUS+7--:6YQ_GJ>@RZ+SI1NG0ZEOJ MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q7I[?'U^?W.$A8 M:'B(F*BXR-CH^"DY25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOH1``("`0(# M!04$!08$"`,#;0$``A$#!"$2,4$%41-A(@9Q@9$RH;'P%,'1X2-"%5)B)$@Q=4DP@)"A@9)C9%&B=D=%4W\J.SPR@IT^/S MA)2DM,34Y/1E=865I;7%U>7U1E9F=H:6IK;&UN;V1U=G=X>7I[?'U^?W.$A8 M:'B(F*BXR-CH^#E)66EYB9FIN.S=Q7L,VF/30(>;S]HY8RH)5_RN_P#, M+_?;?\"W],G^4@U?RGF=_P`KO_,+_?;?\"W],?RD%_E/,LD_/7SY'_>#A7IR MY#]8Q_*00>U,P6?\K\\[?SK]YP_DX(_E7*[_`)7YYV_G7[SC^3@O\JY7?\K\ M\[?SK]YQ_)P7^56+>_OU*W,GV@>N:[/`1E0=_H\LIXP3S9-E+E.Q5V*NQ5V*NQ5)O M,'F_R]H-N\^I7B1\!4Q@@R?\#6N60Q2ER:,VHAC%R+R;S+_SDE#&[1Z!9">, M@@33\D(]P,S(:'^<749NV1_`'G.J_F_Y^U.1E34I;>-]O0A.QKVZ9EQTT!T= M;D[0S2ZH&UT[S]Y@E"JEW-ML\@95H?>F$RA%A&&;)WIU9_D1^8=W'S2UA0?\ M62A3^(R!U<`W1[*S'HF$/_..WGIHF:7ZNDH^R@E#`_3D#K8-@['R^2&D_(;\ MR;3]\D,-5Z&.8%OP&2_.8RQ/96<;_I2JYL_S-\N,HK=PB,U#1!G`^FAR8..3 M3*.?'_.3+0_SS\]:7+_IDYU$+UCN"0?IH,A/20/+9MQ=J98$MI>DO4++4;&^B$MG<1SQD5K& MP;KXTS#,2.;M8S$N18G^8?YG:/Y0LRK,)]2D!]"V4UH?%Z?9R[#@,SY.'K-; M'"/Z3Y[N_P`X/S"NK^2:/6)[:.5ZK!&1P4'L*C-H--`#D\[+M',3?$0^H_*E MU<77EO3KFYD,L\L"-)(>K,1NK]L@$T^[,O38HSYNK[1U4\5<+R_\`Y7?^87^^V_X%OZ9F?E(.J_E/ M,[_E=_YA?[[;_@6_IC^4@O\`*>9H_GC^8"@ED8`=20W],?RD%_E3,I?\K\\[ M?SK]YP_DX,?Y5RN_Y7YYV_G7[SC^3@O\JY7?\K\\[?SK]YQ_)P7^5 M=OYU^\X_DX+_`"KE55_/+S^Z\D0LIZ$!B/U8/RD&7\J9F_\`E=_YA?[[;_@6 M_IC^4@O\IYG?\KO_`#"_WVW_``+?TQ_*07^4\ST'\G_S"\S^9-5N+?5481(O M)200*T]\Q=3AC`;.Q[.U>3+(B3UW,)W#L5=BKL5=BKL5=BKL5=BKL5?_T/2\ MOEO099#))8Q.YZL5WR?'+O:CA@>BS_"OEW_JWP_\#CXDN]?`AW._PKY=_P"K M?#_P./B2[U\"'<\:_P"^NU\K>7>(_P!Q M\/0?LYI/$EWO8>!#N;_PKY=_ZM\/_`X^)+O3X$.YW^%?+O\`U;X?^!Q\27>O M@0[DPMK6WMHA%;QB.,=$789$FVR,0-@JX$NQ5V*NQ52N[RUL[=[BZE6&&,5> M1R``![G"!?)C*0`LO#_S!_YR!"F73_+`J=U>^:JLK#;X!WS88='UDZ+5]K?P MX_\`3/$-3U74=4NFN]0N'N;A_M2.:G-A&(`H.CGDE(W(V4[\E>0->\VWGHZ? M%2!"/6N&V51WH3U.5YCT_9N/&-QQ%GL$$,$2Q0H(XT%%110`9CDV[``#DOP)=BKL56R1QR MHTDY:7>R0(?M1J?A/S&3GBC+F&G#J9X_I*7:GJE_JE[)>W\S7%U*:O(YJ3D MXQ`%!KG,R-GFAXO[U?F,)8A]I>2O^43TK_F'3]6:'+]1>VTW]W'W)UE;>[%7 M8JA;W2M.O@!>6Z3\?L\Q6F2$B.3"6.,N80G^%?+O_5OA_P"!P^)+O8^!#N=_ MA7R[_P!6^'_@LT&& M!Q`D,O\`\*^7?^K?#_P.4>)+OIIV4=SDH0,C0:\N6,(\4N3Y=_,G\U]5\UW3V\#M;Z0IHEN"?C`_:;-O@ MTX@/-Y76Z^64T-H,!S)=>GODORI>^9]?@TNV'VSRF?\`EC!^(Y7ER"$;+D:; M`YS29)F1LO8X<,<<>&*:Y!M=B MKL5=BKL5=BKL54+ZPL[^UDM+V%9[:4<9(G%01A!(-AC.`D*/)\Q_FY^54_E> M\;4=.0R:+.VU.L3'7[0T!Q'BC]#S3,MU:Z+^]7YC$I M#[2\E?\`*)Z5_P`PZ?JS0Y?J+VVF_NX^Y.LK;W8J[%78J[%78JD/GS_E$=4_ MXP/^K+,/U!Q]5_=R]SXOS?/$NQ5V*NQ5]=?D]_Y+_2O^,0S2:GZR]CV=_FV,U[>2".W@4O(Q\!X88Q)-!C.8B+/) M\J_FC^9M[YOU(Q0L8M'@8_5X/YO\MA_-FYT^`0'F\EKM:4;KRMYBN-.E!,5><$G9D;<4^6;O#D$XV\;J].<4S%CT7]ZOS&6EQP^TO M)7_*)Z5_S#I^K-#E^HO;:;^[C[DZRMO=BKL5=BKL5=BJ0^?/^41U3_C`_P"K M+,/U!Q]5_=R]SXOS?/$NQ5V*NQ5]=?D]_P"2_P!*_P",0S2:GZR]CV=_#2O^ M,K?\1S8:#F71=M;Z"Y.D_O8^]] MFI]A?D,T+VH;Q5V*NQ5V*N)`!)V`ZG%7SG^>OYDMJ.H/Y=TR4_4[5N-VZG9Y M!V![C-II,%#B+S?:FMXCP1Y!X[FT_3T'%;>%4"^'?-#DE2I5WNI[6T_'#B'.+YHBVE4> M^;8O,!]H^2O^43TK_F'3]6:'+]1>VTW]W'W)UE;>[%78J[%78J[%4A\^?\HC MJG_&!_U99A^H./JO[N7N?%^;YXEV*NQ5V*OKK\GO_)?Z5_QB&:34_67L>SO[ MF+-,HLC$ M'I\+`Y7E-1+D::/%D`\WVD.F:%[9V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5#ZA90WU ME/:3"L+M_SC1:>J6759.-:CX17,_P#/'N=)_(H_ MG/8]%TX:;I-K8!BXMHUC#GJ>.8,I6;=UCAPQ`[D;D6;L5=BKL5=BKL52'SY_ MRB.J?\8'_5EF'Z@X^J_NY>Y\7YOGB78J[%78J^NOR>_\E_I7_&(9I-3]9>Q[ M._N8LTRAS78J[%78J[%78J[%78J[%78J[%78J[%7_]7U3BKL5=BKQ#_G)C_> M#2O^,K?\1S8:#F71=M;Z"Y.D_O M8^]]FI]A?D,T+VH;Q5V*NQ5Q-!4XJ^6_SW\SR:KYPDL5;E:Z;^[B(.Q+;MFX MTF.HWWO*=JY^/)72+S7,IUCL5=BK-/R>@CF\_:P=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJ0^?/\` ME$=4_P",#_JRS#]0L7L=EI=U=2&BQ1.U?H-,E$6:89)<,27Q-J M=U+=:A'G*R2AL+!V*NQ5F_P"3'_DP=/\`]E^K,?5? M07/[-_O@^M\TKU[L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML52'SY_RB.J?\8'_`%99A^H./JO[N7N?%^;YXEV*NQ5V*OKK\GO_`"7^E?\` M&(9I-3]9>Q[._N8LTRAS78J[%78J[%78J[%78J[%78J[%78J[%7_U_5.*NQ5 MV*O$/^!P>TO[B3Y' MS=/'NQ5V*NQ5F_Y,?^3!T[_9?JS'U7T%S^SO[X/K?-*]>[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%4A\^?\HCJG_&!_U99A^H./JO[N7N M?%^;YXEV*NQ5V*OKK\GO_)?Z5_QB&:34_67L>SO[F+-,H:O&OVC&"/H8'+],:F'"[0%X9/D(BAIX9NWCG8J[%78J]"_(>.. M3\Q[(.H8"*8@'Q";',;6?W9=CV4/WX?5F:9ZUV*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I#Y\_P"41U3_`(P/^K+,/U!Q]5_=R]SXOS?/ M$NQ5V*NQ5]=?D]_Y+_2O^,0S2:GZR]CV=_#2O^,K?\1S8:#F71=M;Z"Y.D_O8^]]FI]A?D,T+VH;Q5V*NQ5+?,FG M#4=#O;,[^K$P'SIMDX2H@M6:'%`A\47<3174T;#B4=@0?8YOAR>(D**EA8NQ M5V*O1/R$('YD65?]]3?\0S&UG]V79=E?WX^+ZJS3/6.Q5V*NQ5V*M.Z(I=R% M5=RQV`&*DI:?-'EL$@ZI:@C8CUD_KD_#EW-7CP_G!K_%7EK_`*NMK_R.3^N/ MAR[E\>'\X._Q5Y:_ZNMK_P`CD_KCX6O^KK:_P#(Y/ZX^'+N M7QX?S@[_`!5Y:_ZNMK_R.3^N/AR[E\>'\X._Q5Y:_P"KK:_\CD_KCX6O^KK:_\`(Y/ZX^'+N7QX?S@[_%7EK_JZVO\`R.3^N/AR[E\>'\X. M_P`5>6O^KK:_\CD_KCX6O\`JZVO_(Y/ZX^'+N7QX?S@B;+5 M]*OF*V=Y#<,O41.KD?<SO[F+-,H#2O^,K?\1S8:#F71=M;Z"Y.D_O8^]]FI]A?D,T+VH;Q5V*NQ5IE#*5/0BA^G%7R-^; MGE]]&\ZWT86EO,WJ0'Q#;G\FGQ0#QW:&+@RGN87E[A.Q5V*LX_)=RGY@Z M>0W'[0K]&8^J^@N?V:?WP?6V:5Z]V*NQ5V*NQ5":M:/>:;:)+B5UN(`K.67XNQ-E^7/R-\Q:YI$.I6\T2 M13BJACOF)/5QB:=GA[+GDCQ!,O\`H7#S5_RT0?\`!9'\]%M_D;)WAGWY2_E; MJ_E"_N;F^DC<3+Q7@:YC:G4"8V=AV?H98227J>8;MG8J[%4A\^?\HCJG_&!_ MU99A^H./JO[N7N?%^;YXEV*NQ5V*OKK\GO\`R7^E?\8AFDU/UE['L[^YBS3* M'-=BKL5=BKL5=BKB`10]#BJ!N+5XB9(#0=U&8\\9&X9`MP:@#\,HH>E<89N] M2$:""*@U&9`+%V*NQ5V*O__4]4XJ[%78J\0_YR8_W@TK_C*W_$(@Q5]H^1K+ZGY2TN$J%;ZO&S`>+*#FARFY%[;2QX<<1Y)[E;D.Q M5V*NQ5V*I#Y\_P"41U3_`(P/^K+,/U!Q]5_=R]SXOS?/$NQ5V*NQ5]=?D]_Y M+_2O^,0S2:GZR]CV=_#2O^,K?\1S8:#F71=M;Z"Y M.D_O8^]]FI]A?D,T+VH;Q5V*NQ5V*J=Q!%<0202CE'*I1U/<,*'"#2"+%/D[ M\U_(%SY5\P2F*,_HJZ)>TD`V`_E)\/U5>>G:,'XCE6:?#$ER=)B,\@#['@A2 M&%(4%$C4*H]@*9HB7M`*%+\4NQ5V*NQ5V*I#Y\_Y1'5/^,#_`*LLP_4''U7] MW+W/B_-\\2[%78J[%7UU^3W_`)+_`$K_`(Q#-)J?K+V/9W]S%FF4.:[%78J[ M%78J[%78J[%7$`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`T9/Q#*\N,3C3D:;.<4Q(/KWRUYDTWS!I<-_8RK(DB MAG0&I0GLV:2<#$T7L,.:.2-A-<@W.Q5V*NQ5V*NQ5`:[K%IHVDW.HW3A(K=" MU6-*D#9?F$`/%9LG M',R[TNR34X`DT'4],5>O?D_^45QJMTFLZU$T6GPL&AA<4,C#<&G\N86IU-;# MF[CL[L\S/%+Z7T=%%'%&L4:A(T%%4=`!FJ>E`I=BEV*NQ5V*NQ5V*I#Y\_Y1 M'5/^,#_JRS#]043#VR,ALJ2'JL/^%Y9F\3!_]#T3<^??*=M,89]1A21>JEM]\M&&1Z./+5XP:)4O^5C>3?^ MKI!_P6/@3[F/YS%_.#O^5C>3?^KI!_P6/@3[E_.8OYP>0_\`.0/F71-8LM-3 M3KI+AHY&+\#6@*YG:/&8DVZ?M;/"8'";>*9GNC=BKL53OR3=06OFS2[B=PD, M4ZL[G8`97E%Q+?II`9(D][ZM7\QO)H5?]RD'0?M9I_`GW/6_G,7\X-_\K&\F M_P#5T@_X+!X$^Y?SF+^<'?\`*Q_)G_5T@_X+'P)]R_G,7\X)YI^HV>H6RW-I M*LT#_9=34'*Y1(YN1"8D+")P,G8J[%78JI7=I;7=O);7,:RP2CC)&PJ"/?"# M2)1!%%XOY_\`R`AN6EO_`"VPBE:K-:-L@`W^#,_#K*VDZ35]D@[P^3P[5M`U MC29FBU"TDMRI*@NI`-/`]\V$9B7)T.3%*!J0I,O)WGK7/*E\+G3Y*QDUDMF/ MP/\`,9#+A$QNVZ?53Q&XOH7R?^=_E;7$2&\D^HWH'[WU-HZ_Y+'-9ETDH\MW MHM/VGCGL?26?6FIZ?>*&M;F.=3T*,&_5F,8D/&-R^Y>Q1QQQ1K'&H5$`"J.@`S!=R!2[%+L5=BKL52W5_,>C: M.$.HW26_/[/,TKDXP,N35DS1A]1I+/\`E8WDW_JZ0?\`!9+P)]S5^62%U1`VY)&68L,A M(;-.IU>,XR`7R?FY>1=BKL5=BKZ>_*[SOY7L/).FVMW?Q0W$48#HS4(.:G48 MI&9(#U.AU6..(`EE?_*QO)O_`%=(/^"RCP)]SE_G,7\X._Y6-Y-_ZND'_!8^ M!/N7\YB_G!,-(\TZ#J\K1:?>1W#KNRH:G(RQF/-LQYX3^DVFN0;G8J[%78J[ M%78JYOLGY8E4B;[1^>:XLVL51_(\?^>/\ MBO\`(T^\._Z%O\R?\M<'WX_GHK_(T^\._P"A;_,G_+7!]^/YZ*_R-/O#O^A; M_,G_`"UP??C^>BO\C3[P[_H6_P`R?\M<'WX_GHK_`"-/O#O^A;_,G_+7!]^/ MYZ*_R-/O#C_SC?YEIM=P5^>/YZ*_R-D[P]K\@^6I_+GERWTN=E>2+J5W&8&: M?%*W>:3"<EJ5I'=(`0HD%:5\,E&9C MR:\F*,QZA;S+S%_SCOY?O"\^FSR6TQZ1;>GF7#6R'-U>;LB!WB:>>ZK_`,X_ M>=+,-)"8;B('X>#?%]V94=9`NNR=DY8\MTE'EW\SM#JEK#>1JA']P"1^&3X\ MHK5_$8/#Q'N9#/J1_.7?XV_-K_?E[_P M#?TQ\+%Y)_,ZC^D@KC6_S6OF*23:C)7I&%:GW`9(0QCN8'+J)?SD'!Y"\\:I M/ZDFGW!DD.\DRD??7"GF+/6R/)V.'LB$=Y&WINDZ%I M&D0^CIMI':QG8B,4K3QS$E,RYNTQXHP%1%([(MCL5=BKL5=BKL5><_FS^6VH M^<1:_4Y4C:WZ\S3KF5ILXAS=;K]%+-5/./\`H6_S)_RUP??F5^>BZS^1I]X= M_P!"W^9/^6N#[\?ST5_D:?>'?]"W^9/^6N#[\?ST5_D:?>'?]"W^9/\`EK@^ M_'\]%?Y&GWAW_0M_F3_EK@^_'\]%?Y&GWAW_`$+?YD_Y:X/OQ_/17^1I]X=_ MT+?YD_Y:X/OQ_/17^1I]X=_T+?YD_P"6N#[\?ST5_D:?>'?]"W^9/^6N#[\? MST5_D:?>'?\`0M_F3_EK@^_'\]%?Y&GWAG/Y4_E3JOE#5)[N\FCD$B\5"'VS M'U&H$Q0<_0:"6&1)>J9ANV=BKL5=BKL5=BK3FB$^V`\E2(]3FO+-V*H[]G_G MC_QMF1_Q*'__TO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ59)!#(09$#$=*BN-H(!6_4[7_?2_<,-E>$-I;P1MR2-5/B!C:@! M4P)=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BJ&N[B+@8U<&1@2J]R`:'*\IJ*QW*5LK`T(H??,)L:Q0F'#X?\` MGC_',FO]RQ?_T_5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*I1YI\SZ9Y;TF74;^0*D8/!.[-X#)X\9D:#3GSQ MQ1XB^;/-/YO>W+-OBTD8C=Y74]J9)G8\/N8_)Y@ M\Y*5E_2=RK)]EBW3+3IX':@XPUF4;W)G/D3\Z;ZSNH=-\Q`SVLA""[&\G(D` M$[=,UNK[-!WAL7;Z+M@\I[C_`&3W6WX3&-HV$D;1I$;$6^F5CDC'0R5K4YM]%BJ-] M[RO;&H,I\(_A2_RMY8$RHQ0,S#E4]`,NRY::=)I15GFRF\\ETMR1'7;]OH:^9=%%K*>(HIJ5]B,S(2X@Z348O#E8>Z_D!K<^J^5WBN3RDTZ3T$ MJ=^-*U_'-)K,`CDXAU>H[*SF>*C_``O5,H=F_P#_U?5.*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*ODG\R$]+\T M]=5_^6GF?DZJP_7F]TO]V'B^TA6>7]9G_DA[<)'RW`W8?Y.8V9VVE(IZ+J\U M@=*<*59BO[L#J,Q(`V[+(1PO"O/31DRT[L.-,VF!YSM#DS/_`)QL2X(U5U(^ MKAP&'?EQVS#U_,.?V>Z9KGH'_UO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N)`%3L,505QJ"J>,>Y[G,?)FZ!D M`^;_`,\/+<^G>9!K:!FM[_>>4]!)L`M?EFY[,U'%'A/.+R_;6EJ?$/XO]TE7 MEKS2+<(I:CJ*`G[)'@3T2I6M$7N23F7&/"'3YLIRRVY/HK\D/*<^@^45EN5*W.HD7#J?M M+M0`YIM7DXI>YZOLS3^'CWYR>AYBNR?_U_5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5QK3;KBJD+A*\7^$CN>AR`GWII5!!%1N,FAV*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*H>:]BCV!Y'VRJ64!-)?/=RR]30>`S&ED)94HY!4!KFAZ=KFF2Z;J$8DMY1U M[JW\R^^68LLL%^8_R3\SZ9-)+I7^FV(/P(N\E/<5S?Z?M* M,]CL7F=5V-..\?4$DB_+CSU+*L7Z,D3D:`RF60EE2CE:NQ5V*J\%I)*>E%\3ED M,9*DIG!`D*T7Z3F5&`#&U3)H=BKL5=BK_]'U3BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BJR2&.0485]\C*(*H*73F!K$?ORB6'N96H^K=0G>M/? MID.*455H]3;]M?NR8S]ZTKI?P-[?/+!F!12NLT3=&!R8D$+LDKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5:+*.II@)53>Z@45+`_+(G(`FD.^I M1_L`D^^5G..BTAY+^=^GP_+*CF)32'9W;[1)^>5DDI:P*[%78JJ1P2R'X5V/ M?MDHP)6T=;Z>B4:3XF\.V9$,('-B2C``!0;`9>AV*NQ5V*NQ5V*O_]+U3BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK3(K"C"HP$6J&ET^% M]U^$^V52P@IM"2:?,FX^(93+"0FU`K(AW!7*Z(2N6XF7HYPB96E5=0G7P/SR M8S%%*JZF_P"TH^C)C.M*@U.+NIR0SA%+QJ$!\1DO&"TO%Y`33EA\0+2X7,!_ M;&'C"*;]>'^'^JWZU!_,,'B!:6&^@'?!XH32TZE`.Q.1\<+2FVIK^RN1.=:4VU.7LH&1. M]G;]JGRR!RDII2:61OM,3D#(E5N!78J[%78JX`DT`J<:57BLIY.W$>^ M61Q$K:,AT^)*%OB/AVR^.$!C:*554444&6@(;PJ[%78J[%78J[%78J__T_5. M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5ID1OM` M'YX"`54)+&!STX_+*SB!3:'?3#^PWWY6<'U?EE9Q$)M2,4B]5(R' M"56X%=BKL5=BKL5=4XJ[%78J[%78J[%78J[%78J[%78JO6"5NBG)")6U=-/G M;Q/\`NQ1\F&0,(=ZV M5-K2T_9F7_@AD3CCWIM8UI%VF3_@AD3C'>MK#:C_`']'_P`$,CX?F$VT;?;^ M\3_@A@X/,+:WT?\`+7[Q@X5=Z/\`EK]XQX5=Z/\`EK]XQX5=Z/\`EK]XQX5; M%O4?WB#_`&0P\'FMKA:@_P"[8Q_LAA\/S"VN6TB[S)_P0PC&.\(M46TM/VIE M^AADQCCWK:JEO8K_`+L4_P"R&2$(=Z+*LJV@^SPK\QDP(JK"E-NF3"'85=BK 7L5=BKL5=BKL5=BKL5=BKL5=BKL5?_]D_ ` end -----END PRIVACY-ENHANCED MESSAGE-----